Psychiatry and Neurology, Neurology · New York, NY
NPI
1760526164
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
205 E 111th St
New York, NY, 10029
Phone (646) 864-0213
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
698 services
Medicare patients, 2024
30
Average age 69
Drug cost, 2024
$1.6M
5,561 prescriptions
Company payments, 2025
$2,082
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose C Cabassa was code 99214 (office e&m - established), 21 times for 15 patients. In total Jose C Cabassa billed 698 services in 15 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 21 | 15 | $102.60 | $2,155 |
By year: 2022 $17K for 933 services; 2023 $13K for 503 services; 2024 $12K for 698 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose C Cabassa prescribed most often to Medicare patients was Gabapentin, with 1,302 prescriptions and refills. In total Jose C Cabassa wrote 5,561 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,302 | 1,416 | 265 | $5,565 |
| Baclofen Generic | 832 | 900 | 165 | $3,760 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 653 | 875 | 108 | $9,531 |
| Donepezil Hcl Generic | 471 | 576 | 94 | $2,345 |
| Quetiapine Fumarate Generic | 365 | 373 | 62 | $1,991 |
| Botox Onabotulinumtoxina | 185 | 541 | 64 | $247K |
| Nuplazid Pimavanserin Tartrate | 151 | 151 | 20 | $728K |
| Diclofenac Sodium Er Diclofenac Sodium | 133 | 133 | 14 | $11K |
| Selegiline Hcl Generic | 118 | 146 | 23 | $3,948 |
| Rytary Carbidopa/Levodopa | 107 | 108 | 15 | $36K |
| Tizanidine Hcl Generic | 91 | 95 | 18 | $975 |
| Nourianz Istradefylline | 88 | 88 | 11 | $170K |
| Memantine Hcl Generic | 86 | 114 | 18 | $814 |
| Risperidone Generic | 74 | 85 | 12 | $382 |
| Amantadine Amantadine Hcl | 63 | 93 | 14 | $1,973 |
Brand drugs: 743 claims; generic drugs: 4,818 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose C Cabassa $2,082 ($2,082 in general payments such as food, travel and fees) from 19 companies. The largest payer was Neurelis, Inc. with $354.
| Company | Payments | Amount |
|---|---|---|
| Neurelis, Inc. | 19 | $354 |
| Amneal Pharmaceuticals LLC AMRX | 16 | $325 |
| Lundbeck LLC | 11 | $213 |
| ACADIA Pharmaceuticals Inc ACAD | 10 | $195 |
| Abbvie Inc. ABBV | 10 | $188 |
| Lilly USA, LLC LLY | 8 | $149 |
| Celgene Corporation BMY | 6 | $128 |
| Eisai Inc. 4523.T | 4 | $82.28 |
| Genentech USA, Inc. ROG.SW | 3 | $71.13 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $59.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.